SunOpta Highlights Long-Term Growth Strategies at Investor Day

Rhea-AI Summary

SunOpta Inc. (Nasdaq:STKL) hosted its 2022 Investor Day, revealing a strong financial outlook. Projected revenue is expected to rise to $1.3 billion by 2025, with Adjusted EBITDA estimated at $150 million. The company reaffirmed its guidance for 2022 with revenues of $890 million to $930 million and adjusted EBITDA of $67 million to $75 million. For 2023, revenue is anticipated to reach $1.1 billion and adjusted EBITDA of $100 million.

Positive

• Projected revenue growth to $1.3 billion in 2025.
• Adjusted EBITDA forecasted to reach $100 million in 2023 and $150 million in 2025.
• Reaffirmed guidance for 2022 with anticipated revenue of $890-$930 million and adjusted EBITDA of $67-$75 million.

Negative

• None.

Revenue projected to increase to $1.3 billion in 2025

Adjusted EBITDA^1,2 projected to reach $100 million in 2023 and $150 million in 2025

MINNEAPOLIS--(BUSINESS WIRE)-- SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a U.S.-based, global pioneer fueling the future of sustainable, plant-based and fruit-based food and beverages, yesterday hosted its 2022 Investor Day.

“I would like to thank everyone who attended our Investor Day in person or online through our webcast. Our strategic transformation over the past several years has put SunOpta in an enviable leadership position within the fastest growing plant-based categories,” said Joe Ennen, Chief Executive Officer of SunOpta. “Industry trends remain strong and we will continue to leverage our competitive advantages to drive significant gains in revenues and profitability, maximizing value for shareholders.”

Investor Day Highlights

The event outlined SunOpta’s differentiated capabilities and long-term strategies to drive value for shareholders including sources of competitive advantage and foundations of growth. Financial highlights included:

• Reaffirmed 2022 guidance²:
  • Revenue $890 million - $930 million, Adjusted EBITDA¹ $67 million – 75 million
• Reaffirmed 2023 outlook²
  • Revenue $1.1 billion and Adjusted EBITDA¹ of $100 million
• Provided 2025 outlook²
  • Revenue $1.3 billion and Adjusted EBITDA¹ of $150 million

Investors interested in listening to a replay of the Investor Day webcast can access a link on SunOpta’s website at www.sunopta.com under the “Investor Relations” section. The replay of the webcast will be archived and can be accessed for approximately 90 days.

¹ See discussion of non-GAAP measures

² The Company has included certain forward-looking statements about the future financial performance that include non-GAAP financial measures, including Adjusted EBITDA. These non–GAAP financial measures are derived by excluding certain amounts, expenses or income, from the corresponding financial measures determined in accordance with GAAP. The determination of the amounts that are excluded from these non-GAAP financial measures is a matter of management judgment and depends upon, among other factors, the nature of the underlying expense or income amounts recognized in a given period. We are unable to present a quantitative reconciliation of the aforementioned forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures because management cannot reliably predict all of the necessary components of such GAAP measures. Historically, management has excluded the following items from certain of these non-GAAP measures, and such items may also be excluded in future periods and could be significant amounts.

• Expenses related to the acquisition or divestiture of a business, including business development costs, impairment of assets, integration costs, severance, retention costs and transaction costs;
• Start-up costs of new facilities and equipment;
• Charges associated with restructuring and cost saving initiatives, including but not limited to asset impairments, accelerated depreciation, severance costs and lease abandonment charges;
• Asset impairment charges and facility closure costs;
• Legal settlements or awards; and
• The tax effect of the above items.

About SunOpta Inc.

SunOpta (Nasdaq:STKL) (TSX:SOY) is a U.S.-based, global pioneer fueling the future of sustainable, plant-based and fruit-based food and beverages. Founded nearly 50 years ago, SunOpta manufactures natural, organic and specialty products sold through retail and foodservice channels. SunOpta operates as a manufacturer for leading natural and private label brands, and also proudly produces its own brands, including SOWN, Dream, WestSoy and Sunrise Growers. For more information, visit www.sunopta.com and LinkedIn.

Forward-Looking Statements

Certain statements included in this press release may be considered "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, which are based on information available to us on the date of this release. These forward-looking statements include, but are not limited to, our belief that investment in plant-based foods and beverages will continue to be a significant driver of revenue and margin growth, and our ability to drive further year-over-year adjusted EBITDA improvement. Generally, forward-looking statements do not relate strictly to historical or current facts and are typically accompanied by words such as “continue”, “expect”, “believe”, “anticipate”, “estimates”, “can”, “will”, “target”, "should", "would", "plans", "becoming", "intend", "confident", "may", "project", "potential", "intention", "might", "predict", “budget”, “forecast” or other similar terms and phrases intended to identify these forward-looking statements. Forward-looking statements are based on information available to the Company on the date of this release and are based on estimates and assumptions made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments including, but not limited to, the Company’s actual financial results; uninterrupted operations and service levels to our customers during COVID-19; current customer demand for the Company’s products and the additional anticipated demand due to COVID-19; general economic conditions; continued consumer interest in health and wellness; the Company’s ability to maintain product pricing levels; planned facility and operational expansions, closures and divestitures; cost rationalization and product development initiatives; alternative potential uses for the Company’s capital resources; portfolio optimization and productivity efforts; the sustainability of the Company’s sales pipeline; the Company’s expectations regarding commodity pricing, margins and hedging results; improved availability and field prices for fruit; procurement and logistics savings; freight lane cost reductions; yield and throughput enhancements; and labor cost reductions. Whether actual timing and results will agree with expectations and predictions of the Company is subject to many risks and uncertainties including, but not limited to, potential loss of suppliers and customers as well as supply chain, logistics and other disruptions resulting from or related to COVID-19; unexpected issues or delays with the Company’s structural improvements and automation investments; failure or inability to implement portfolio changes, process improvements, go-to-market improvements and process sustainability strategies in a timely manner; changes in the level of capital investment; local and global political and economic conditions; consumer spending patterns and changes in market trends; decreases in customer demand; delayed or unsuccessful product development efforts; potential product recalls; working capital management; availability and pricing of raw materials and supplies; potential covenant breaches under the Company’s credit facilities; and other risks described from time to time under "Risk Factors" in the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q (available at www.sec.gov). Consequently, all forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized. The Company undertakes no obligation to publicly correct or update the forward-looking statements in this document, in other documents, or on its website to reflect future events or circumstances, except as may be required under applicable securities laws.

Non-GAAP Measures

In addition to reporting financial results in accordance with U.S. GAAP, the Company provides additional information about its operating results regarding segment operating income, adjusted earnings and adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”), which are not measures in accordance with U.S. GAAP. The Company believes that segment operating income, adjusted earnings and adjusted EBITDA assist investors in comparing performance across reporting periods on a consistent basis by excluding items that are not indicative of its operating performance. The non-GAAP measures of segment operating income, adjusted earnings and adjusted EBITDA should not be considered in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP.

In order to evaluate its results of operations, the Company uses certain other non-GAAP measures that it believes enhance an investor’s ability to derive meaningful period-over-period comparisons and trends from the results of operations. In particular, the Company evaluates its revenues on a basis that excludes the effects of fluctuations in commodity pricing and the impacts of acquisitions and divestitures. In addition, the Company excludes specific items from its reported results that due to their nature or size, it does not expect to occur as part of its normal business on a regular basis. These non-GAAP measures are presented solely to allow investors to more fully assess the Company’s results of operations and should not be considered in isolation of, or as substitutes for an analysis of the Company’s results as reported under U.S. GAAP.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220603005125/en/

Reed Anderson

ICR

646-277-1260

reed.anderson@icrinc.com

Source: SunOpta Inc.

FAQ

What is SunOpta's revenue projection for 2025?

SunOpta projects revenue to increase to $1.3 billion by 2025.

What is the adjusted EBITDA forecast for SunOpta in 2023?

The adjusted EBITDA for SunOpta is expected to be $100 million in 2023.

What are the 2022 revenue expectations for SunOpta?

SunOpta has reaffirmed its 2022 revenue guidance, expecting between $890 million and $930 million.

How is SunOpta addressing shareholder value according to the latest Investor Day?

The CEO stated that the company will leverage competitive advantages to drive significant gains in revenues and profitability to maximize shareholder value.